NYSE MKT
ELMD

Electromed Inc

Medical Devices
Healthcare

Prices are adjusted according to historical splits.

Electromed Inc Stock Price

Vitals

Today's Low:
$10.79
Today's High:
$11.03
Open Price:
$10.87
52W Low:
$8.75
52W High:
$13.84
Prev. Close:
$10.98
Volume:
7592

Company Statistics

Market Cap.:
$104.53 million
Book Value:
4.253
Revenue TTM:
$45.72 million
Operating Margin TTM:
6.58%
Gross Profit TTM:
$31.44 million
Profit Margin:
5.5%
Return on Assets TTM:
4.6%
Return on Equity TTM:
7.15%

Company Profile

Electromed Inc had its IPO on 2010-08-13 under the ticker symbol ELMD.

The company operates in the Healthcare sector and Medical Devices industry. Electromed Inc has a staff strength of 156 employees.

Stock update

Shares of Electromed Inc opened at $10.87 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $10.79 - $11.03, and closed at $10.79.

This is a -1.73% slip from the previous day's closing price.

A total volume of 7,592 shares were traded at the close of the day’s session.

In the last one week, shares of Electromed Inc have increased by +7.47%.

Electromed Inc's Key Ratios

Electromed Inc has a market cap of $104.53 million, indicating a price to book ratio of 2.4876 and a price to sales ratio of 2.0092.

In the last 12-months Electromed Inc’s revenue was $45.72 million with a gross profit of $31.44 million and an EBITDA of $3.59 million. The EBITDA ratio measures Electromed Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Electromed Inc’s operating margin was 6.58% while its return on assets stood at 4.6% with a return of equity of 7.15%.

In Q1, Electromed Inc’s quarterly earnings growth was a positive 71.4% while revenue growth was a positive 19%.

Electromed Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
42.1035
PEG
0

Its diluted EPS in the last 12-months stands at $0.29 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Electromed Inc’s profitability.

Electromed Inc stock is trading at a EV to sales ratio of 1.8654 and a EV to EBITDA ratio of 25.4473. Its price to sales ratio in the trailing 12-months stood at 2.0092.

Electromed Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$42.84 million
Total Liabilities
$6.42 million
Operating Cash Flow
$-558000.00
Capital Expenditure
$558000
Dividend Payout Ratio
0%

Electromed Inc ended 2024 with $42.84 million in total assets and $0 in total liabilities. Its intangible assets were valued at $42.84 million while shareholder equity stood at $36.39 million.

Electromed Inc ended 2024 with $0 in deferred long-term liabilities, $6.42 million in other current liabilities, 86000.00 in common stock, $17.76 million in retained earnings and $0 in goodwill. Its cash balance stood at $6.78 million and cash and short-term investments were $6.78 million. The company’s total short-term debt was $0 while long-term debt stood at $0.

Electromed Inc’s total current assets stands at $35.17 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $23.13 million compared to accounts payable of $1.29 million and inventory worth $3.45 million.

In 2024, Electromed Inc's operating cash flow was $-558000.00 while its capital expenditure stood at $558000.

Comparatively, Electromed Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$10.79
52-Week High
$13.84
52-Week Low
$8.75
Analyst Target Price
$20.5

Electromed Inc stock is currently trading at $10.79 per share. It touched a 52-week high of $13.84 and a 52-week low of $13.84. Analysts tracking the stock have a 12-month average target price of $20.5.

Its 50-day moving average was $10.46 and 200-day moving average was $10.92 The short ratio stood at 2.75 indicating a short percent outstanding of 0%.

Around 2498.8% of the company’s stock are held by insiders while 3543.9% are held by institutions.

Frequently Asked Questions About Electromed Inc

The stock symbol (also called stock or share ticker) of Electromed Inc is ELMD

The IPO of Electromed Inc took place on 2010-08-13

Similar Industry Stocks (Medical Devices)

Last Price
Chg
Chg%
$31.25
-1.15
-3.55%
$14.53
-0.65
-4.28%
$49.02
-0.87
-1.74%
NOV Inc. (NOV)
$21.24
0.34
+1.63%
$4
0.16
+4.17%
JSW Energy Limited (JSWENERGY)
$397.45
-34.05
-7.89%
$157.25
-7.3
-4.44%
CytRx Corp (CYTR)
$0.18
0.02
+10.97%
$905.3
-47.6
-5%
$9.72
-0.28
-2.8%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care and institutional markets for patients with bronchiectasis, cystic fibrosis, and neuromuscular diseases. It markets its products primarily to physicians and health care providers, as well as directly to patients. The company was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Address

500 Sixth Avenue NW, New Prague, MN, United States, 56071